Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

A Macrophage is a Macrophage is a Macrophage—in Metastasis

News

August 23, 2023
PRESS RELEASE: On June 6, 2023, a new editorial was published in Oncotarget, entitled, “A macrophage is a macrophage is a macrophage—in metastasis.” continue reading »

Aggressive Luminal Breast Cancer: Are Cis-Spliced Fusion Proteins Pathological?

News

August 21, 2023
PRESS RELEASE: On June 12, 2023, a new editorial paper was published in Oncotarget, entitled, “Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?” continue reading »

Inhibiting Glutamine Metabolism Impacts Tumor Cells or the Microenvironment?

News

August 16, 2023
PRESS RELEASE: On August 10, 2023, a new editorial was published in Oncotarget, entitled, “Inhibition of glutamine metabolism: acting on tumoral cells or on tumor microenvironment?” continue reading »

Peripheral Surrogates of Tumor Burden to Guide Therapeutic Strategies for HPV-Associated Malignancies

News

August 14, 2023
PRESS RELEASE: On August 10, 2023, a new review paper was published in Oncotarget, entitled, “Peripheral surrogates of tumor burden to guide chemotherapeutic and immunotherapeutic strategies for HPV-associated malignancies.” continue reading »

Whole-Genome Doubling and Aneuploidy in Human Cancer

Oncotarget

August 10, 2023
In a new editorial paper, researchers from Tel Aviv University discuss a recent study exploring how whole-genome doubling shapes the aneuploidy landscape of human cancers. continue reading »